Nasus Pharma NSRX
NYSE NSRX
$3.50 +0.27 (+8.41%)
As of: Oct 23, 2026 · 3:57 PM EDT

Nasus Pharma (NSRX) Cash & Current Investments (2024 - 2026)

Updated

Nasus Pharma (NSRX) reported Cash & Current Investments of $11.82 million for Q2 2026, compared with $232,000 a year earlier.

Analysis

Nasus Pharma (NSRX) Cash & Current Investments (2024 - 2026) Analysis & Trends

At the end of FY2025, Nasus Pharma posted Cash & Current Investments of $4.29 million.

  • By year, Cash & Current Investments came in at $311,000 in FY2024 (+48.1%) and $210,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Nasus Pharma 27.67 Mn 10.97 Mn - 11.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.82 Mn
Dec 31, 2025 4.34 Mn
Jun 30, 2025 232,000.00
Dec 31, 2024 311,000.00
API Access

Nasus Pharma Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NSRX&period=max&api_key=YOUR_API_KEY